Literature DB >> 3834416

The effects of neurotensin, naloxone and haloperidol on elements of excessive grooming behavior induced by bombesin.

T J Van Wimersma Greidanus, D K Donker, R Walhof, J C Van Grafhorst, N De Vries, S J Van Schaik, C Maigret, B M Spruijt, D L Colbern.   

Abstract

The influence of naloxone, haloperidol and neurotensin was investigated on bombesin-induced excessive grooming in rats. All three drugs reduced the amount of bombesin-induced grooming. Haloperidol induced a general reduction in excessive grooming as induced by bombesin, without changing the composition of grooming behavior, whereas naloxone and neurotensin suppressed bombesin-induced grooming and caused a shift in the distribution of grooming elements. The main suppressive effect of these latter drugs appeared to be on the element scratching. From these data it is suggested that bombesin-induced scratching is mainly displayed by activation of opiate receptor systems, whereas the other elements of bombesin-induced excessive grooming are mainly regulated by dopaminergic systems.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3834416     DOI: 10.1016/0196-9781(85)90447-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  The effects of the phyllolitorin analogue [desTrp(3), Leu(8)]phyllolitorin on scratching induced by bombesin and related peptides in rats.

Authors:  M D Johnson; M Ko; K S Choo; J R Traynor; H I Mosberg; N N Naughton; J H Woods
Journal:  Brain Res       Date:  1999-08-21       Impact factor: 3.252

2.  Characterization of scratching responses in rats following centrally administered morphine or bombesin.

Authors:  H Lee; N N Naughton; J H Woods; M C H Ko
Journal:  Behav Pharmacol       Date:  2003-11       Impact factor: 2.293

3.  Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice.

Authors:  Mary F Divin; M C Holden Ko; John R Traynor
Journal:  Eur J Pharmacol       Date:  2008-01-24       Impact factor: 4.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.